Oasmia issues new shares for acquiring an asset corresponding to SEK 25 million
Uppsala, Sweden, Oct. 24, 2016 (GLOBE NEWSWIRE) – As previously announced on October 24 2016 Oasmia has acquired a novel cancer project which was paid for by 3,080,000 newly issued shares at a share price of approximately SEK 8.12 per share
In order to enable the transaction, the Board of Directors of Oasmia has, pursuant to the authorization granted by the annual general meeting held on September 26, 2016, resolved on a directed issue of 3,080,000 new shares.
Through the issue, the number of shares in Oasmia increases by 3,080,000 from 115,959,310 to 119,039,310 and the share capital increases by SEK 308,000 from SEK 11,595,931 to SEK 11,903,931. The new issue results in an equity dilution of approximately 2.6 percent after the issue is completed.
The information above has been made public in accordance with the Securities Market Act and the Financial Instruments Trading Act.
Notes to editors:
About Oasmia Pharmaceutical AB
Oasmia Pharmaceutical AB develops, manufactures, markets and sells new generations of drugs in the field of human and veterinary oncology. The company’s product development aims to create and manufacture novel nanoparticle formulations and drug-delivery systems based on well-established cytostatics which, in comparison with current alternatives, show improved properties, reduced side-effects, and expanded applications. The company’s product development is based on its proprietary in-house research and company patents. Oasmia is listed on NASDAQ Capital Markets (OASM.US), Frankfurt Stock Exchange (OMAX.GR, ISIN SE0000722365) and NASDAQ Stockholm (OASM.ST).
Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the constituent information in accordance with the rules and regulations prevailing in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Oasmia Pharmaceutical AB (publ) securities in any jurisdiction, neither from Oasmia Pharmaceutical AB (publ) nor anyone else.
Oasmia enters into collaboration agreement for novel cancer project
Uppsala, Sweden, Oct. 24, 2016 (GLOBE NEWSWIRE) – Oasmia acquires the project and strengthens its oncology project portfolio. Karo Pharma receives 3,080,000 newly issued shares as a down payment corresponding to a value of MSEK 25. Additionally, Oasmia will pay Karo Pharma 20% of all future revenues generated by the project for Oasmia.
Oasmia will continue the development process and will be responsible for all project expenses.
“This is a solid industrial solution where the companies can focus within their respective areas. Oasmia, which has several cancer projects in both early and late developmental phase, strengthens its already unique product portfolio. The collaboration is based on a separation of focus that will work well and I am personally committed to making this a successful collaboration for both companies” says Anders Lonner, Executive Chairman in Karo Pharma.
“This is a very exciting acquisition for Oasmia as the project will complement the company’s current product portfolio with novel innovative candidates within our focus area. A prerequisite in this transaction from our side has been to get access to Anders Lonners unique track record in developing companies and his international business experience. Since we are looking forward to several registrations of new pharmaceutical products, his expertise will be very valuable. Anders Lonner is proposed to be part of Oasmia’s Board of Directors and will also be proposed as chairman at an extraordinary shareholders meeting.” says Julian Aleksov, largest shareholder in Oasmia Pharmaceutical.
Stockholm Corporate Finance has been advising Oasmia in this transaction.
About Oasmia Pharmaceutical AB
Oasmia Pharmaceutical AB develops, manufactures, markets and sells new generations of drugs in the field of human and veterinary oncology. The company’s product development aims to create and manufacture novel nanoparticle formulations and drug-delivery systems based on well-established cytostatics, which, in comparison with current alternatives, show, improved properties, reduced side-effects, and expanded applications. The company’s product development is based on its proprietary in-house research and company patents. Oasmia is listed on NASDAQ Capital Markets (OASM.US), Frankfurt Stock Exchange (OMAX.GR, ISIN SE0000722365) and NASDAQ Stockholm (OASM.ST).
About Karo Pharma AB
Karo Pharma is a Health Care company, which develops and markets products for pharmacies, regular shops and directly to the Health Care community. The share is listed on Nasdaq Stockholm.
'When he cried, he cried alone': The story Gord Downie felt he had to tell
After 50 years of struggling to bring attention to what happened to her brother, Pearl Achneepineskum is finally seeing his story told on a national stage.
That’s thanks to Gord Downie, who’s multimedia project Secret Path tells the story of Achneepineskum’s brother Chanie Wenjack, a 12-year-old boy who died of exposure in 1966 while running away from an residential school.
“I’ve worked for so many years to do that. I was glad when it finally came out,” said Achneepineskum on Metro Morning.
Downie, who was diagnosed with brain cancer after starting the project, was inspired to make an album, film and graphic novel about Wenjack after reading a decades-old magazine article about him.
Achneepineskum sees it as intervention from the universe.
“The creator moves mountains, and that’s how Gord came to read the magazine story about my brother,” she said. “He wanted to do something meaningful.”
When she first saw the Secret Path film, Achneepineskum said she “stood there crying throughout the whole process.”
‘When he cried, he cried alone’
Achneepineskum remembers saying goodbye to her brother Chanie the day he was taken away to the Cecilia Jeffrey Indian Residential School near Kenora, Ontario.
“We looked at each other. I knew, looking at him, that he was really sad to go,” she said.
She imagines what he went through at the school, which was more than 400 kilometers from their home.
“There wasn’t only abuse. There was also loneliness. He didn’t have us, he was just by himself. When he decided to go, he wanted to go home,” she said.
“When he cried, he cried alone.”
Through the pain of his death, Achneepineskum remembers the little boy she knew.
“He was mischievous. He had a wicked sense of humour… He always felt that he had to do something for you.”
CBC to air Secret Path film October 23
CBC television will broadcast the film component of Secret Path on Sunday, October 23 at 9 p.m. ET.
The film combines illustrations by Jeff Lemire and Gord Downie’s music.
Produced AVON 39, a 7-Market Breast Cancer Crusade Uniting Thousands of Men and Women Through a 39.3 Mile Walk
A woman has a 1 in 8 chance of developing breast cancer in her lifetime and as a company that is 71% women, we enthusiastically joined the fight against Breast Cancer through our strong partnership | work | relationship with AVON 39 - The Walk to End Breast Cancer.
AVON 39 The Walk to End Breast Cancer, a project of the Avon Breast Cancer Crusade, is a two-day, 39.3 mile-long walking event to raise awareness and money for research and access to care. Since 2003, nearly 200K Walkers have raised over $580M+ and over the course of the past year, LeadDog has led AVON 39 nationally with events in seven key markets: Houston, Washington DC, Chicago, Boston, San Francisco, Santa Barbara, and New York.
LeadDog, together with Avon Breast Cancer Crusade (ABCC), has been responsible for recruitment of participants, fundraising, and production of the event series. From first registering participants, to supporting Walkers in both training and fundraising, to mapping the route, and securing and activating sponsors, LeadDog’s role in AVON 39 is indispensable.
As we wind down the end of our first season with AVON 39, we celebrate many tremendous accomplishments during the 2016 season including the participation of nearly 18,000 Walkers who raised over $30 million to take down Breast Cancer. LeadDog also introduced exciting new partners to the AVON 39 team, including Del Monte Fruit Refreshers, KIND Snacks, LYFT, Cello Whisps, and Don Francisco’s Coffee, to name a few.
This past weekend, in honor of Breast Cancer Awareness month, LeadDoggers also laced up their shoes to support of the mission and represented the agency in our home city with “Team LeadDog.” The team literally put themslves in the participant’s shoes – including training, walking and fundraising - just as the incredible participants do in each of the seven cities. Our outstanding LeadDog team contributed to the AVON 39 fundraising by exceeding the team’s $25,000 goal and pounding the pavement during a glorious fall New York weekend.
LeadDoggers have worked tirelessly on the AVON 39 for over a year now, and are already in full swing of 2017 planning since the 2017 season kicks off again in just a few months with the first event of the season in April 2017 in Houston.
Gord Downie pumpkin heading to Toronto for fundraising auction
Gourd Downie is going on tour.
A pumpkin carved with an accurate likeness of Tragically Hip frontman Gord Downie in full-throated performance drew a lot of social media attention for Summerside's Chris Gilfoy earlier this year.
Now, the longtime Hip fan will carve the same image into a new pumpkin, which will be shipped to Toronto’s Sunnybrook Hospital where it will be auctioned off to raise money for the Gord Downie Fund for Brain Cancer Research.
Downie is suffering from glioblastoma, an aggressive brain cancer with no cure.
As he toured with the Hip on their Man Machine Poem tour and announced a new solo project, the cancer research fund earned more than $800,000 as of mid-September.
‘It makes me a little bit nervous’
Gilfoy told CBC News he was contacted by a doctor in Sunnybrook’s neurology department asking if a similar pumpkin could be shipped to Toronto.
“We’ve been in touch with a courier who’s willing to send it out for next-day delivery,” said Gilfoy, who said a carved pumpkin without candles in it can last for four days.
Gilfoy, who has been carving pumpkins for about 12 years, considered a new pattern for the pumpkin, but finally decided none of the other photos he could work from “quite captured Gord the way this one does” singing with a lot of heartfelt emotion.
“It makes me a little bit nervous, because I knew in the past if I screwed it up I could always just throw it away or do another one or not post the pictures or something like that,” he said.
“But there’s a little bit of pressure to make sure this one turns out just perfect.”
Not accepting pay
Gilfoy said he’s so thrilled to create a pumpkin that will help people that he turned down offers from Sunnybrook to pay for the pumpkin or the time he puts into it.
“There was just no way I was having that,” he said.
Instead, Gilfoy just wants to know how much money it goes for at auction.
“That’s what I’m looking forward to the most, actually, is to find out just how much good it did.”
- MORE P.E.I. NEWS | Driver accused of hit and run sought after cyclist struck by car
- MORE P.E.I. NEWS | Mrs. Dunster’s expands bakery operations in P.E.I.
Alright guys, so I need some help. I’m kinda stuck on Max’s route. I’m not sure how I want it to play out. So, I’m turning to you guys!
Please reblog this and add what you’d like to see happen in Max’s route!
Put it in the tags, add it as a comment, or make it a reply, it doesn’t matter. If you give me a super mega spicy idea and I end up using it in the game, you will be credited as contributing to the final product, and will be listed as part of the team!
Some backstory to help you: the game is set at a college in a rural area. Max is majoring in film, and wants to become a director one day. His personality is going to be how he acts on camera: loud, touchy, curious, vulgar, etc. All the characters are sophomores. The main character is a freshman.
If you don’t know what the hell this post is talking about, I’m making a cancer crew themed dating sim! More info in the faq :)
I know I only have 450 followers but this is really important to me. I’m raising money towards cancer research bc my dad passed away due to lung cancer it’s a project for school as well I need all the help I can get reblog please 💕💕